Please set your featured image
OMD sponsors International Conference on Breath Research
Begbroke Science Park based company Oxford Medical Diagnostics (OMD ), developer of breath based, medical diagnostic technology for the rapid, non-invasive, accurate and low-cost diagnosis and monitoring of metabolic and infectious diseases, announced on 2nd September 2011 it is the principal sponsor of the 2011 International Conference on Breath Research, which is held in Parma, Italy on 11-14 September.
The summit provides a forum for clinicians, scientists, engineers and environmentalists to present their latest findings as well as meet with key industry figures to discuss current trends and the future direction of upcoming technologies in breath analysis.
“The International Conference on Breath Research attracts leading academics from 33 countries, some of whom will provide lectures during the event,” said Prof. Gus Hancock, OMD’s science director and chair of the companies Science Advisory Panel.
“This is an excellent opportunity to not only discuss but also to advance the growing field of breath analysis by recognizing the importance of collaborative working.”
OMD is currently developing new techniques to analyze human breath for the screening, diagnosis and monitoring of diabetes. The company is also active in the measurement of breath gases during and after exercise, and in the monitoring of the effect of diet on breath output. OMD also specializes in mass spectrometry and new sensor technologies, both areas which will be a focus of this year’s event.
“We are proud, as a leading breath diagnostics company, to be the principal sponsor of the International Conference on Breath Research, the most significant event in the field of breath analysis,” said John Jack, chairman, OMD. “We are committed to supporting this event and have already agreed to sponsor the 2012 event, which will be held in our home town in Oxford.”
Representatives from OMD will be giving academic presentations at the event. In particular, Professor Terence Risby, who also sits on the Science Advisory Panel, will be presenting on ‘Methodological aspects of VOC collection’ at 9:00 am on 13 September. Professor Risby will also chair a conference session on breath tests in different clinical conditions.
The summit is jointly organized by the International Association for Breath Research (IABR) and the University and Municipality of Parma.
“We are very pleased to host the International Conference on Breath Research,” said Professor Massimo Corradi, associate producer at the University of Parma and co-director of the Conference.
“We are committed to providing the highest scientific standards through our rigorous selection of speakers, who are all top scientists in their respective specialties.”
OMD will sponsor the 2012 International Conference on Breath Research, which will be held in Oxford on 16-19 September, 2012.
About Oxford Medical Diagnostics
Oxford Medical Diagnostics Ltd is developing a unique blend of technology that makes it possible to provide rapid, accurate and low-cost diagnosis and monitoring of disease and metabolic functions through the simple and non-invasive analysis of breath. Its initial objective is to bring to market a non-invasive point-of-care (at-patient) diagnostic instrument to detect diabetes. The OMD approach is based on development of breath analysis, potentially a highly accurate method of diagnosis.
The companies expertise also allows it to offer an industrial gas analysis service, giving it on-going revenue stream. Proprietary and patented technologies within OMD include Cavity Enhanced Absorption Spectroscopy (CEAS), based on tunable diode lasers, Broadband Cavity Enhanced Absorption Spectroscopy (BBCEAS), which uses super-luminescent light emitting diodes and Plasma Emission Spectroscopy (PES). OMD has already assembled a highly experienced management team whose members have excellent track records of success in company development and technology.
The company has raised GBP 1.91 million in funding from its management team and private investors. It maintains close links with the University of Oxford and academics around the world.
For more information, please visit http://www.omdiagnostics.com
About the International Association for Breath Research
The International Association for Breath Research (IABR) was founded in 2005. Its editorial board consists of leading researchers in this field including its current chairman Professor Anton Amann.
It aims to promote scientific research and development in the field of breath analysis and to encourage the development of breath analysis for clinical diagnosis and therapeutic monitoring. The IABR holds an annual conference on breath analysis and also founded the Journal of Breath Research: Volatiles for Medical Diagnoses.
For more information, please visit http://www.breathsummit2011.it